Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -364,811 | -168,312 | -17,492 | -715,075 | -479,372 |
| Depreciation Amortization | 19,623 | 11,076 | 5,245 | 24,500 | 10,404 |
| Accounts receivable | -30,948 | -13,149 | -15,996 | -41,835 | -18,988 |
| Other Working Capital | 586,465 | 717,046 | 716,968 | -66,881 | -74,745 |
| Other Operating Activity | 71,672 | -26,474 | -60,935 | 342,828 | 270,033 |
| Operating Cash Flow | $282,001 | $520,187 | $627,790 | $-456,463 | $-292,668 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -49,711 | -129,758 | -115,437 | 521,994 | 486,623 |
| PPE Investments | -53,592 | -28,289 | -9,120 | -59,631 | -42,374 |
| Net Acquisitions | N/A | N/A | N/A | -172,556 | -172,556 |
| Purchase Sale Intangibles | 108,069 | 108,069 | 108,069 | N/A | N/A |
| Other Investing Activity | 105,473 | 106,142 | 106,877 | -3,082 | -2,048 |
| Investing Cash Flow | $2,170 | $-51,905 | $-17,680 | $286,725 | $269,645 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 245,625 | N/A |
| Common Stock Issued | 360,184 | 341,395 | 323,820 | 401,955 | 389,925 |
| Other Financing Activity | -4,798 | -4,798 | -4,798 | -5,026 | -4,337 |
| Financing Cash Flow | $355,386 | $336,597 | $319,022 | $642,554 | $385,588 |
| Beginning Cash Position | 843,645 | 843,645 | 843,645 | 370,829 | 370,829 |
| End Cash Position | 1,483,202 | 1,648,524 | 1,772,777 | 843,645 | 733,394 |
| Net Cash Flow | $639,557 | $804,879 | $929,132 | $472,816 | $362,565 |
| Free Cash Flow | |||||
| Operating Cash Flow | 282,001 | 520,187 | 627,790 | -456,463 | -292,668 |
| Capital Expenditure | -53,592 | -28,289 | -9,120 | -59,631 | -42,374 |
| Free Cash Flow | 228,409 | 491,898 | 618,670 | -516,094 | -335,042 |